Ladetto M - Search Results

1

Reduced-intensity conditioning followed by allografting of hematopoietic cells can produce clinical and molecular remissions in patients with poor-risk hematologic malignancies.

Corradini P, Tarella C, Olivieri A, Gianni AM, Voena C, Zallio F, Ladetto M, Falda M, Lucesole M, Dodero A, Ciceri F, Benedetti F, Rambaldi A, Sajeva MR, Tresoldi M, Pileri A, Bordignon C, Bregni M. Corradini P, et al. Among authors: ladetto m. Blood. 2002 Jan 1;99(1):75-82. doi: 10.1182/blood.v99.1.75. Blood. 2002. PMID: 11756155 Free article.

2

The mutation of N-ras oncogene does not involve myeloid and erythroid lineages in a case of multiple myeloma.

Corradini P, Ferrero D, Voena C, Ladetto M, Boccadoro M, Pileri A. Corradini P, et al. Among authors: ladetto m. Br J Haematol. 1993 Apr;83(4):672-3. doi: 10.1111/j.1365-2141.1993.tb04711.x. Br J Haematol. 1993. PMID: 7686038 No abstract available.

3

N- and K-ras oncogenes in plasma cell dyscrasias.

Corradini P, Ladetto M, Inghirami G, Boccadoro M, Pileri A. Corradini P, et al. Among authors: ladetto m. Leuk Lymphoma. 1994 Sep;15(1-2):17-20. doi: 10.3109/10428199409051673. Leuk Lymphoma. 1994. PMID: 7858496 Review.

4

High-dose sequential chemoradiotherapy in multiple myeloma: residual tumor cells are detectable in bone marrow and peripheral blood cell harvests and after autografting.

Corradini P, Voena C, Astolfi M, Ladetto M, Tarella C, Boccadoro M, Pileri A. Corradini P, et al. Among authors: ladetto m. Blood. 1995 Mar 15;85(6):1596-602. Blood. 1995. PMID: 7888677 Free article.

5

Mutational activation of N- and K-ras oncogenes in plasma cell dyscrasias.

Corradini P, Ladetto M, Voena C, Palumbo A, Inghirami G, Knowles DM, Boccadoro M, Pileri A. Corradini P, et al. Among authors: ladetto m. Blood. 1993 May 15;81(10):2708-13. Blood. 1993. PMID: 8490179 Free article.

6

Long-term molecular remission after conventional chemotherapy in a patient with Philadelphia-negative acute lymphoblastic leukemia.

Ladetto M, Corradini P, Astolfi M, Campana S, Tarella C, Pileri A. Ladetto M, et al. Haematologica. 1996 Mar-Apr;81(2):159-61. Haematologica. 1996. PMID: 8641647

7

Clinical and molecular remission after allogeneic blood cell transplantation in a patient with mantle-cell lymphoma.

Corradini P, Ladetto M, Astolfi M, Voena C, Tarella C, Bacigalupo A, Pileri A. Corradini P, et al. Among authors: ladetto m. Br J Haematol. 1996 Aug;94(2):376-8. doi: 10.1046/j.1365-2141.1996.d01-1816.x. Br J Haematol. 1996. PMID: 8759900

8

Molecular monitoring of minimal residual disease in follicular and mantle cell non-Hodgkin's lymphomas treated with high-dose chemotherapy and peripheral blood progenitor cell autografting.

Corradini P, Astolfi M, Cherasco C, Ladetto M, Voena C, Caracciolo D, Pileri A, Tarella C. Corradini P, et al. Among authors: ladetto m. Blood. 1997 Jan 15;89(2):724-31. Blood. 1997. PMID: 9002976 Free article.

9

Analysis of the immunoglobulin heavy-chain gene rearrangement providing molecular evidence of second lymphoma in a patient in apparent relapse after autotransplantation.

Campana S, Corradini P, Astolfi M, Ladetto M, Cinque F, Novero D, Tarella C, Pileri A. Campana S, et al. Among authors: ladetto m. Bone Marrow Transplant. 1997 Aug;20(4):341-3. doi: 10.1038/sj.bmt.1700887. Bone Marrow Transplant. 1997. PMID: 9285551

10

A novel nested-PCR strategy for the detection of rearranged immunoglobulin heavy-chain genes in B cell tumors.

Voena C, Ladetto M, Astolfi M, Provan D, Gribben JG, Boccadoro M, Pileri A, Corradini P. Voena C, et al. Among authors: ladetto m. Leukemia. 1997 Oct;11(10):1793-8. doi: 10.1038/sj.leu.2400801. Leukemia. 1997. PMID: 9324303

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

223 results

Search Page